CTEPH
MCID: PLM101
MIFTS: 37

Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis (CTEPH)

Categories: Blood diseases, Cardiovascular diseases, Rare diseases, Respiratory diseases

Aliases & Classifications for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

MalaCards integrated aliases for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis:

Name: Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis 56
Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis, Susceptibility to 56 13
Chronic Thromboembolic Pulmonary Hypertension 58 71
Cteph, Dvt-Negative, Susceptibility to 56
Cteph, Dvt-Negative 56
Cteph 58

Characteristics:

Orphanet epidemiological data:

58
chronic thromboembolic pulmonary hypertension
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe); Age of onset: Adult;

Classifications:

Orphanet: 58  
Rare respiratory diseases


External Ids:

OMIM 56 612862
UMLS via Orphanet 72 C2363973
Orphanet 58 ORPHA70591
UMLS 71 C2363973

Summaries for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

MalaCards based summary : Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis, also known as pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to, is related to chronic thromboembolic pulmonary hypertension and pulmonary hypertension. An important gene associated with Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis is CTEPH1 (Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis, Susceptibility To). The drugs Selexipag and Treprostinil have been mentioned in the context of this disorder. Affiliated tissues include lung, heart and endothelial, and related phenotypes are fatigue and edema

More information from OMIM: 612862

Related Diseases for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

Diseases related to Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 145)
# Related Disease Score Top Affiliating Genes
1 chronic thromboembolic pulmonary hypertension 13.1
2 pulmonary hypertension 11.5
3 pulmonary embolism 11.1
4 pulmonary hypertension, primary, 1 11.1
5 cardiac arrest 10.8
6 tricuspid valve insufficiency 10.6
7 pulmonary edema 10.5
8 antiphospholipid syndrome 10.5
9 vascular disease 10.5
10 thrombophilia due to thrombin defect 10.5
11 syncope 10.5
12 thrombosis 10.4
13 respiratory failure 10.4
14 thrombophilia 10.4
15 lung disease 10.4
16 hypothyroidism 10.3
17 vasculitis 10.3
18 sarcoidosis 1 10.3
19 pulmonary disease, chronic obstructive 10.3
20 hydrocephalus 10.3
21 hemopericardium 10.3
22 pericardial effusion 10.3
23 pulmonary venoocclusive disease 10.3
24 connective tissue disease 10.3
25 mediastinitis 10.3
26 fibrosing mediastinitis 10.3
27 pulmonary venoocclusive disease 1, autosomal dominant 10.2
28 sleep apnea 10.2
29 hepatic veno-occlusive disease 10.2
30 sarcoma 10.2
31 spindle cell sarcoma 10.2
32 congestive heart failure 10.2
33 heritable pulmonary arterial hypertension 10.2
34 cardiogenic shock 10.2
35 autoimmune disease 10.1
36 varicose veins 10.1
37 inflammatory bowel disease 10.1
38 osteomyelitis 10.1
39 nasopharyngitis 10.1
40 heart disease 10.1
41 cardiac tamponade 10.1
42 nephrotic syndrome 10.1
43 hemosiderosis 10.1
44 thrombocytopenia 10.1
45 post-thrombotic syndrome 10.1
46 pleural empyema 10.1
47 pulmonary artery disease 10.1
48 47,xyy 10.1
49 sickle cell disease 10.1
50 posttransplant acute limbic encephalitis 10.1

Graphical network of the top 20 diseases related to Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis:



Diseases related to Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis

Symptoms & Phenotypes for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

Human phenotypes related to Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis:

58 (show all 37)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 fatigue 58 Frequent (79-30%)
2 edema 58 Occasional (29-5%)
3 congestive heart failure 58 Very frequent (99-80%)
4 pulmonary arterial hypertension 58 Very frequent (99-80%)
5 osteomyelitis 58 Very rare (<4-1%)
6 autoimmunity 58 Occasional (29-5%)
7 obesity 58 Occasional (29-5%)
8 depressivity 58 Occasional (29-5%)
9 inflammation of the large intestine 58 Very rare (<4-1%)
10 neoplasm 58 Very rare (<4-1%)
11 pulmonary embolism 58 Frequent (79-30%)
12 syncope 58 Occasional (29-5%)
13 right bundle branch block 58 Occasional (29-5%)
14 reduced vital capacity 58 Frequent (79-30%)
15 elevated c-reactive protein level 58 Occasional (29-5%)
16 abnormality of blood and blood-forming tissues 58 Occasional (29-5%)
17 exertional dyspnea 58 Frequent (79-30%)
18 abnormal t-wave 58 Occasional (29-5%)
19 deep venous thrombosis 58 Frequent (79-30%)
20 antiphospholipid antibody positivity 58 Occasional (29-5%)
21 myeloproliferative disorder 58 Very rare (<4-1%)
22 central sleep apnea 58 Occasional (29-5%)
23 left ventricular dysfunction 58 Occasional (29-5%)
24 palpitations 58 Frequent (79-30%)
25 increased hdl cholesterol concentration 58 Occasional (29-5%)
26 increased pulmonary vascular resistance 58 Very frequent (99-80%)
27 right ventricular failure 58 Occasional (29-5%)
28 lupus anticoagulant 58 Occasional (29-5%)
29 right ventricular dilatation 58 Occasional (29-5%)
30 obstructive deficit on pulmonary function testing 58 Frequent (79-30%)
31 cardiac shunt 58 Occasional (29-5%)
32 recurrent thromboembolism 58 Occasional (29-5%)
33 dysfibrinogenemia 58 Occasional (29-5%)
34 abnormality of von willebrand factor 58 Occasional (29-5%)
35 hypocapnia 58 Occasional (29-5%)
36 right atrial enlargement 58 Occasional (29-5%)
37 increased factor viii activity 58 Occasional (29-5%)

Clinical features from OMIM:

612862

Drugs & Therapeutics for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

Drugs for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 62)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Selexipag Approved Phase 3 475086-01-2
2
Treprostinil Approved, Investigational Phase 3 81846-19-7 6918140 54786
3
Macitentan Approved Phase 3 441798-33-0
4
Ambrisentan Approved, Investigational Phase 3 177036-94-1 6918493
5 Calamus Phase 3
6 Endothelin A Receptor Antagonists Phase 3
7 Fibrinolytic Agents Phase 3
8 Tissue Plasminogen Activator Phase 3
9 Plasminogen Phase 3
10 Endothelin Receptor Antagonists Phase 3
11 Antihypertensive Agents Phase 3
12
Riociguat Approved Phase 2 625115-55-1
13 Xenon Experimental Phase 2 7440-63-3
14 Radiopharmaceuticals Phase 2
15 Anesthetics Phase 2
16 Anesthetics, General Phase 2
17 Anesthetics, Inhalation Phase 2
18
Nitric Oxide Approved Phase 1 10102-43-9 145068
19
Heparin Approved, Investigational 9005-49-6 46507594 772
20
Phylloquinone Approved, Investigational 84-80-0
21
Edoxaban Approved 480449-70-5
22
Warfarin Approved 81-81-2 6691 54678486
23
Rivaroxaban Approved 366789-02-8
24
Acetylcysteine Approved, Investigational 616-91-1 12035
25
Methamphetamine Approved, Illicit 537-46-2 10836
26
Iloprost Approved, Investigational 78919-13-8 6443959
27
Tadalafil Approved, Investigational 171596-29-5 110635
28
Epoprostenol Approved 35121-78-9, 61849-14-7 5282411 5280427
29
Thrombin Approved, Investigational
30
Iodine Approved, Investigational 7553-56-2 807
31
Streptokinase Approved, Investigational 9002-01-1
32
Bosentan Approved, Investigational 147536-97-8 104865
33
Menadione Approved, Nutraceutical 58-27-5 4055
34
Cysteine Approved, Nutraceutical 52-90-4 5862
35 Menaquinone Investigational 1182-68-9
36 Tezosentan Investigational 180384-57-0
37 Immunoglobulins
38 Antibodies
39 Autoantibodies
40 Vitamins
41 naphthoquinone
42 Vitamin K
43 calcium heparin
44 Hemostatics
45 Coagulants
46 Respiratory System Agents
47 Anti-Infective Agents
48 Antidotes
49 Antioxidants
50 Expectorants

Interventional clinical trials:

(show top 50) (show all 127)
# Name Status NCT ID Phase Drugs
1 Efficacy and Safety Evaluation of 12-h and 2-h Urokinase Regimes in the Treatment of Pulmonary Thromboembolism: A Multi-Center, Randomized Controlled Trial in China Completed NCT00799968 Phase 4 Urokinase;Urokinase
2 Efficacy and Safety Evaluation of Low Dosage of Recombinant Tissue Plasminogen Activator (rt-PA) in the Treatment of Pulmonary Thromboembolism: A Multi-Center, Randomized Controlled Trial in China Completed NCT00781378 Phase 4 rt-PA;rt-PA
3 CHANGE-MRI (CTEPH DIAGNOSIS Europe - MRI) Unknown status NCT02791282 Phase 3
4 Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Completed NCT00313222 Phase 3 bosentan
5 Long-term Open-label Extension Study in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Who Completed Protocol AC-052-366 (BENEFIT, NCT00313222) Completed NCT00319111 Phase 3 bosentan
6 Randomized, Double-blind, Placebo-controlled, Multi-centre, Multi-national Study to Evaluate the Efficacy and Safety of Oral BAY63-2521 (1 mg, 1.5 mg, 2 mg, or 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Completed NCT00855465 Phase 3 Riociguat (Adempas, BAY63-2521);Placebo
7 Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Completed NCT00910429 Phase 3 Riociguat (Adempas, BAY63-2521)
8 Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension Completed NCT01884012 Phase 3
9 A Prospective, Multicenter, Open-label, Single Arm, Phase III Study to Assess the Efficacy and Safety of Macitentan (ACT-064992) in Subjects With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Recruiting NCT03809650 Phase 3 macitentan 10 mg
10 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Group-sequential, Adaptive, Phase 3 Study With Open-label Extension Period to Assess the Efficacy and Safety of Selexipag as an add-on to Standard of Care Therapy in Subjects With Inoperable or Persistent/Recurrent After Surgical and/or Interventional Treatment Chronic Thromboembolic Pulmonary Hypertension Recruiting NCT03689244 Phase 3 Selexipag;Placebo
11 A Double Blind Controlled Clinical Study to Investigate the Efficacy and Tolerability of Subcutaneous Treprostinil Sodium in Patients With Severe Non-operable Chronic Thromboembolic Pulmonary Hypertension (CTREPH) Active, not recruiting NCT01416636 Phase 3 Treprostinil sodium
12 A Prospective, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel Group, Adaptive Phase 3 Study With Open-label Extension to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension Not yet recruiting NCT04271475 Phase 3 Macitentan;Placebo
13 A Reduced Dose of Thrombolytic Treatment for Patients With Intermediate High-risk Acute Pulmonary Embolism Not yet recruiting NCT04430569 Phase 3 Alteplase;Placebo
14 A Randomised, Multicentre, Double-Blind, Placebo-Controlled Study Of Ambrisentan In Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Terminated NCT01884675 Phase 3 Ambrisentan 5 mg;Placebo
15 An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Terminated NCT01894022 Phase 3 Ambrisentan 5 mg
16 Randomized Pilot Trial of Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy Unknown status NCT02745106 Phase 2
17 Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel-group, 24-week Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension Completed NCT02021292 Phase 2 Macitentan;Placebo
18 Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects Completed NCT02886793 Phase 1, Phase 2 fludeoxyglucose
19 Evaluation of Right Ventricular Function and Metabolism Following Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension- Images of Rio Completed NCT02094001 Phase 2
20 Effect of Short-term Oxygen Therapy on Cardiopulmonary Exercise Capacity in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension Completed NCT01748474 Phase 2
21 A Multicenter, Non-randomized, Non-blinded, Noncontrolled Study to Investigate the Impact of Multiple Doses of BAY 63-2521 on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients With Pulmonary Hypertension in a 12-week 3 Times a Day Individual Dose Titration Scheme Completed NCT00454558 Phase 2 Riociguat (Adempas, BAY63-2521)
22 A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Multicentre, Prospective Study to Assess Efficacy of Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy With High Preoperative Pulmonary Vascular Resistance Recruiting NCT03273257 Phase 2 Riociguat;Placebo
23 Prospective, Randomized, Controlled Trial of the Effect of Long-term Oxygen Therapy on 6-minute Walking Distance, Clinical Parameters and Hemodynamics in Patients With PAH and CTEPH Recruiting NCT04207593 Phase 2 Oxygen
24 MERIT-2 : Long Term, Multicenter, Single-arm, Open-label Extension Study of the MERIT-1 Study, to Assess the Safety, Tolerabilty and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Active, not recruiting NCT02060721 Phase 2 Macitentan
25 Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging Suspended NCT03078192 Phase 2 GE-141, Hyperpolarized 129Xenon gas
26 Compassionate Use of Catheter Thrombectomy (Aspirex 11F) in Patients With Massive Pulmonary Embolism Terminated NCT00314002 Phase 1, Phase 2
27 A Non-randomized Two Part Multi-Center, Open-label, Single Dose Trial With an Escalation Part in Untreated Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Patients (Part A), Followed by a Parallel Group Part in Untreated and Pre-treated Patients With PAH and CTEPH (Part B) to Investigate the Safety, Tolerability and Pharmacodynamics of Inhaled BAY1237592 Recruiting NCT03754660 Phase 1 BAY1237592;PH-monotherapy;PH-combination therapy
28 A Phase I Study of the Safety and Feasibility of Central Intravenous Delivery of Allogeneic Human Cardiosphere-Derived Stem Cells in Patients With Pulmonary Arterial Hypertension ALPHA Trial Recruiting NCT03145298 Phase 1
29 Local Registry of Patients With Chronic Thromboembolic Pulmonary Hypertension in Novosibirsk Region Unknown status NCT03349164
30 Inspiratory Muscle Training in Patients With Chronic Thromboembolic Pulmonary Hypertension: a Randomized Controlled Trial Unknown status NCT03102294
31 Incidence of CTEPH in Dependence of Thrombus Location in Patients With Acute Pulmonary Embolism and Index Fibrinolysis Unknown status NCT01672203
32 Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension Unknown status NCT02634203 Riociguat
33 Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany Unknown status NCT02660463
34 Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment Unknown status NCT02583906
35 Long-term Right Ventricular Resynchronization Therapy for Chronic Thromboembolic Pulmonary Hypertension Unknown status NCT01163422
36 Assessment of Safety and Efficacy of Balloon Pulmonary Angioplasty in Non-operable CTEPH Patients Unknown status NCT02964390
37 Gene Mutations in Secondary Pulmonary Hypertension Unknown status NCT00348803
38 Lung Perfusion Measured With Dual-Energy CT (DECT) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Comparative Study With Right Heart Catheterization and Ventilation/Perfusion Scintigraphy (V/Q) Unknown status NCT03450304
39 Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension Detected by an Artificial Nose: A Clinical Validation Study Unknown status NCT02782026
40 Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China Unknown status NCT01717092
41 Follow-up in Rivaroxaban Patients in Setting of Thromboembolism Unknown status NCT02248610
42 Three-dimensional Echocardiographic Assessment of Right Ventricular Function in Patients Undergoing Pulmonary Endarterectomy Unknown status NCT02426203
43 Retrospective Chart Review of Patients With PAH or Inoperable/Persistent/Recurrent CTEPH Who Transition Their PH Treatment to Adempas Completed NCT02545465 Riociguat (Adempas, BAY63-2521)
44 New International CTEPH Database Completed NCT02656238
45 Identification Of The Predictive Angiographic And Computed Tomographic (CT) Criteria Of The Success Of The Thromboendarterectomy In Chronic Pulmonary Hypertension Completed NCT00657722
46 (e-MOTION PH) Electronic - Activity Level Monitoring Pilot in Pulmonary Hypertension Completed NCT02536534
47 Identification of CTEPH on Standard Computerised Tomography Pulmonary Angiography Performed in the Work-up of Suspected Pulmonary Embolism Completed NCT03083093
48 United States CTEPH Registry Completed NCT02429284
49 A Prospective Single Blind Controlled Study to Assess the Efficacy of a Lung Protective Ventilation Strategy in the Prevention of Reperfusion Lung Injury Following PTE Completed NCT00747045
50 Study on the Clinical Course Of Pulmonary Embolism Completed NCT01781858

Search NIH Clinical Center for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis

Genetic Tests for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

Anatomical Context for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

MalaCards organs/tissues related to Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis:

40
Lung, Heart, Endothelial, Testes, Brain, Smooth Muscle, Liver

Publications for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

Articles related to Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis:

(show top 50) (show all 1932)
# Title Authors PMID Year
1
HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis. 61 56
19165231 2009
2
The potential for early diagnosis of pulmonary arterial hypertension using lung iodine-123-metaiodobenzylguanidine (123I-MIBG) uptake: A case report. 61
32528606 2020
3
Does combination therapy work in chronic thromboembolic pulmonary hypertension? 61
32518816 2020
4
Post-Intensive Care Unit Follow-up of Pulmonary Embolism. 61
32473699 2020
5
A systematic literature review and meta-analysis of spectral CT compared to scintigraphy in the diagnosis of acute and chronic pulmonary embolisms. 61
32112117 2020
6
Validation of Automated Perfusion-Weighted Phase-Resolved Functional Lung (PREFUL)-MRI in Patients With Pulmonary Diseases. 61
31872556 2020
7
Long-term changes of exercise hemodynamics and physical capacity in chronic thromboembolic pulmonary hypertension after pulmonary thromboendarterectomy. 61
32497568 2020
8
Comparison of Balloon Pulmonary Angioplasty and Pulmonary Vasodilators for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis. 61
32483219 2020
9
Virtual Histology to Evaluate Mechanisms of Pulmonary Artery Lumen Enlargement in Response to Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension. 61
32492788 2020
10
Persistent exercise intolerance after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. 61
32366481 2020
11
Effects of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension on remodeling in right-sided heart. 61
32086654 2020
12
Long-term real world clinical outcomes of macitentan therapy in chronic thromboembolic pulmonary hypertension. 61
32421542 2020
13
Balloon Pulmonary Angioplasty with Stent Implantation as a Treatment of Proximal Chronic Thromboembolic Pulmonary Hypertension. 61
32492944 2020
14
Editorial for "Chronic Thromboembolic Pulmonary Hypertension Perioperative Monitoring Using Phase-Resolved Functional Lung (PREFUL)-MRI". 61
32506708 2020
15
CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension (CTEPH). 61
32513780 2020
16
Egg and Banana sign - A Radiological sign of Severe Pulmonary Arterial Hypertension. 61
32539095 2020
17
Quantifying the Influence of Wedge Pressure, Age, and Heart Rate on the Systolic Thresholds for Detection of Pulmonary Hypertension. 61
32419583 2020
18
Novel Insight into How Nurses Working at PH Specialist Clinics in Sweden Perceive Their Work. 61
32575509 2020
19
Gadolinium contrast balloon pulmonary angioplasty for a patient with chronic thromboembolic pulmonary hypertension and severe iodine allergy. 61
32478464 2020
20
Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertension. 61
31976548 2020
21
Assessment of ventilation-perfusion scans in patients with chronic thromboembolic pulmonary hypertension before and after surgery and correlation with clinical parameters. 61
32531708 2020
22
Dual-Energy Computed Tomography as an Alternative Noninvasive Study for Evaluation of Chronic Thromboembolic Pulmonary Hypertension Postoperatively. 61
32397817 2020
23
Chronic Pulmonary Thromboembolic Disease. 61
31902629 2020
24
Ocular hypotonia following pulmonary endarterectomy. 61
31580413 2020
25
Chronic thromboembolic pulmonary hypertension secondary to implantable cardioverter defibrillator lead thrombus in a patient with Brugada syndrome: a rare complication requiring a multidisciplinary approach. 61
32434878 2020
26
Machine Learning and Deep Neural Network Applications in the Thorax: Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension, Aorta, and Chronic Obstructive Pulmonary Disease. 61
32271281 2020
27
Chronic thromboembolic pulmonary hypertension: interventional approaches. 61
32404404 2020
28
Speckle tracking for predicting outcomes of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. 61
32447819 2020
29
The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension. 61
32444403 2020
30
Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study. 61
32397294 2020
31
Balloon pulmonary angioplasty improves quality of life in Japanese patients with chronic thromboembolic pulmonary hypertension. 61
32402668 2020
32
Comparison of V/Q SPECT and CT Angiography for the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension. 61
32427559 2020
33
Balloon pulmonary angioplasty improves right atrial reservoir and conduit functions in chronic thromboembolic pulmonary hypertension. 61
32359071 2020
34
A rare childhood case of Behcet's disease and chronic thromboembolic pulmonary hypertension. 61
32419255 2020
35
Surgical and Percutaneous Interventions for Chronic Thromboembolic Pulmonary Hypertension. 61
32284102 2020
36
Catheter-directed thrombolysis for submassive pulmonary embolism in children: A case series. 61
31876109 2020
37
Intrapulmonary Activated Factor VII for Hemoptysis Complicating Pulmonary Thromboendarterectomy. 61
31470015 2020
38
Imaging of Chronic Thromboembolic Disease. 61
32166427 2020
39
Pulmonary Endarterectomy: Improving Outcomes over Time with Increased Institutional Experience. 61
32465371 2020
40
Single Cell RNA Sequencing of Human Pulmonary Endarterectomy Specimen Reveals Distinct Cell Populations and Gene Profiles. 61
32465398 2020
41
Real-world experience with riociguat as potential bridging therapy in patients with chronic thromboembolic pulmonary hypertension: a case series. 61
32328237 2020
42
Cyclophilin A as a biomarker for the therapeutic effect of balloon angioplasty in chronic thromboembolic pulmonary hypertension. 61
31615744 2020
43
Outcomes of Patients with Chronic Thromboembolic Pulmonary Hypertension Risk Stratified by a Dedicated Heart Team to Receive Pulmonary Endarectomy or Balloon Pulmonary Angiogiplasty. 61
32464975 2020
44
Exercise intolerance in chronic thromboembolic pulmonary hypertension after pulmonary angioplasty. 61
32312861 2020
45
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. 61
31873853 2020
46
The role of inflammation in a rat model of chronic thromboembolic pulmonary hypertension induced by carrageenan. 61
32395536 2020
47
Life expectancy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Swedish single-center study. 61
32313643 2020
48
Chronic thromboembolic pulmonary hypertension in Saudi Arabia: preliminary results from the SAUDIPH registry. 61
32420315 2020
49
Pregnancy in a Patient With Chronic Thromboembolic Pulmonary Hypertension After Successful Treatment with Balloon Pulmonary Angioplasty. 61
32115306 2020
50
Targeted Angiogenesis Gene Expression Profiling of Patients with Chronic Thromboembolic Pulmonary Hypertension. 61
32465370 2020

Variations for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

Expression for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

Search GEO for disease gene expression data for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis.

Pathways for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

GO Terms for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

Sources for Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein...

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....